PL EN


Preferences help
enabled [disable] Abstract
Number of results
2017 | 64 | 1 | 189-193
Article title

Ionizing radiation affects profile of serum metabolites: increased level of 3-hydroxybutyric acid in serum of cancer patients treated with radiotherapy

Content
Title variants
Languages of publication
EN
Abstracts
EN
Radiotherapy causes molecular changes observed at the level of body fluids, which are potential biomarker candidates for assessment of radiation exposure. Here we analyzed radiotherapy-induced changes in a profile of small metabolites detected in sera of head and neck cancer patients using the gas chromatography coupled with mass spectrometry approach. There were about 20 compounds, including carboxylic acids, sugars, amines and amino acids, whose levels significantly differed between pre-treatment and post-treatment samples. Among metabolites upregulated by radiotherapy there was 3-hydroxybutyric acid, whose level increased about three times in post-treatment samples. Moreover, compounds affected by irradiation were associated with several metabolic pathways, including protein biosynthesis and amino acid metabolism.
Publisher

Year
Volume
64
Issue
1
Pages
189-193
Physical description
Dates
published
2017
received
2016-04-11
revised
2016-05-06
accepted
2016-07-14
(unknown)
2016-11-04
Contributors
  • Maria Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland
  • Maria Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland
  • Institute of Bioorganic Chemistry Polish Academy of Sciences, Poznań, Poland
  • Warwick Systems Biology Centre, University of Warwick, Warwick, United Kingdom
  • Maria Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland
author
  • Maria Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland
  • Maria Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland
author
  • Maria Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland
  • Maria Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland
  • Maria Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland
author
  • Maria Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland
References
  • Alsner J, Andreassen CN, Overgaard J (2008) Genetic markers for prediction of normal tissue toxicity after radiotherapy. Semin Radiat Oncol 18: 126-135. doi: 10.1016/j.semradonc.2007.10.004.
  • Amundson SA, Bittner M, Fornace AJ, Jr (2003) Functional genomics as a window on radiation stress signaling. Oncogene 22: 5828-5833. doi: 10.1038/sj.onc.1206681.
  • Bentzen SM (2008) From cellular to high-throughput predictive assays in radiation oncology: challenges and opportunities. Semin Radiat Oncol 18: 75-88. doi: 10.1016/j.semradonc.2007.10.003.
  • Boguszewicz Ł, Hajduk A, Mrochem-Kwarciak J, Skorupa A, Ciszek M, Heyda A, Składowski K, Sokół M (2016) 1H NMR based metabolomic approach to monitoring of the head and neck cancer treatment toxicity. Metabolomics 12: 102. doi: 10.1007/s11306-016-1043-4
  • Goudarzi M, Mak TD, Chen C, Smilenov LB, Brenner DJ, Fornace AJ (2014) The effect of low dose rate on metabolomics response to radiation in mice. Radiat Environ Biophys 53: 645-657. doi: 10.1007/s00411-014-0558-1.
  • Horneck G (1998) Biological monitoring of radiation exposure. Adv Space Res 22: 1631-1641.
  • Jelonek K, Pietrowska M, Roś M, Zagdański A, Suchwałko A, Polańska J, Marczyk M, Rutkowski T, Składowski K, Clench MR, Widłak P (2014) Radiation-induced changes in serum lipidome of head and neck cancer patients. Int J Mol Sci 15: 6609-6624. doi: 10.3390/ijms15046609.
  • Laiakis EC, Strassburg K, Bogumil R, Lai S, Vreeken RJ, Hankemeier T, Langridge J, Plumb RS, Fornace AJ Jr, Astarita G (2014a) Metabolic phenotyping reveals a lipid mediator response to ionizing radiation. J Proteome Res 13: 4143-4154. doi: 10.1021/pr5005295.
  • Laiakis EC, Mak TD, Anizan S, Amundson SA, Barker CA, Wolden SL, Brenner DJ, Fornace AJ (2014b) Development of a metabolomic radiation signature in urine from patients undergoing total body irradiation. Radiat Res 181: 350-361. doi: 10.1667/RR13567.1.
  • Mak TD, Tyburski JB, Krausz KW, Kalinich JF, Gonzalez FJ, Fornace AJ Jr (2015) Exposure to ionizing radiation reveals global dose - and time-dependent changes in the urinary metabolome of rat. Metabolomics 11: 1082–1094. doi: 10.1007/s11306-014-0765-4.
  • Marchetti F, Coleman MA, Jones IM, Wyrobek AJ (2006) Candidate protein biodosimeters of human exposure to ionizing radiation. Int J Radiat Biol 82: 605-639. doi: 10.1080/09553000600930103.
  • McIntyre JO, Churchill P, Maurer A, Berenski CJ, Jung CY, Fleischer S (1983) Target size of D-beta-hydroxybutyrate dehydrogenase. Functional and structural molecular weight based on radiation inactivation. J Biol Chem 258: 953-959.
  • Menard C, Johann D, Lowenthal M, Muanza T, Sproull M, Ross S, Gulley J, Petricoin E, Coleman CN, Whiteley G, Liotta L, Camphausen K (2006) Discovering clinical biomarkers of ionizing radiation exposure with serum proteomic analysis. Cancer Res 66: 1844-1850.
  • Newman JC, Verdin E (2014) Ketone bodies as signaling metabolites. Trends Endocrinol Metab 25: 42-52. doi: 10.1016/j.tem.2013.09.002.
  • Patel RM, Roback JD, Uppal K, Yu T, Jones AP, Josephson CD (2015) Metabolomics profile comparisons of irradiated and nonirradiated stored donor red blood cells. Transfusion 55: 544-552. doi: 10.1111/trf.12884.
  • Shimazu T, Hirschey MD, Newman J, He W, Shirakawa K, Le Moan N, Grueter CA, Lim H, Saunders LR, Stevens RD, Newgard CB, Farese RV Jr, de Cabo R, Ulrich S, Akassoglou K, Verdin E (2013) Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science 339: 211-214. doi: 10.1126/science.1227166.
  • Składowski K, Maciejewski B, Goleń M, Tarnawski R, Ślosarek K, Suwiński R, Sygula M, Wygoda A (2006) Continuous accelerated 7-days-a-week radiotherapy for head-and-neck cancer: long-term results of phase III clinical trial Int J Radiat Oncol Biol Phys 66: 706-713. doi: 10.1016/j.ijrobp.2006.05.026.
  • Spratlin JL, Serkova NJ, Eckhardt SG (2009) Clinical applications of metabolomics in oncology: a review. Clin Cancer Res 15: 431-440. doi: 10.1158/1078-0432.CCR-08-1059.
  • Wang C, Yang J, Nie J (2009) Plasma phospholipid metabolic profiling and biomarkers of rat following radiation exposure based on liquid chromatography-mass spectrometry technique. Biomed Chromatogr 23: 1079-1085. doi: 10.1002/bmc.1226.
  • Widłak P, Pietrowska M, Polańska J, Rutkowski T, Jelonek K, Kalinowska-Herok M, Gdowicz-Kłosok A, Wygoda A, Tarnawski R, Składowski K (2013) Radiotherapy-related changes in serum proteome patterns of head and neck cancer patients; the effect of low and medium doses of radiation delivered to large volumes of normal tissue. J Transl Med 11: 299. doi: 10.1186/1479-5876-11-299.
  • Widłak P, Jelonek K, Wojakowska A, Pietrowska M, Polanska J, Marczak Ł, Miszczyk L, Składowski K (2015) Serum proteome signature of radiation response: upregulation of inflammation-related factors and downregulation of apolipoproteins and coagulation factors in cancer patients treated with radiation therapy - a pilot study. Int J Radiat Oncol Biol Phys 92: 1108–1115. doi: 10.1016/j.ijrobp.2015.03.040.
Document Type
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.bwnjournal-article-abpv64p189kz
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.